Imaging Diagnostic Systems CEO retires
Imaging Diagnostic Systems (IDSI) has reported that Tim Hansen has retired as CEO and director, effective January 1.
Hansen held a number of leadership positions prior to IDSI, including as the president of Picker International, a manufacturer of diagnostic imaging systems, until April 2001, according to the company.
In the interim, Allan Schwartz, the current executive vice president, and Deborah O’Brien, the current senior vice president, will collaboratively work with other IDSI executives in a committee format to manage the daily workings of the company and actively begin the search for a new CEO.
Hansen was hired in 2004, a year after IDSI’s premarket approval (PMA) filing failed to gain FDA approval for its non-invasive CT laser mammography technology. As CEO, Hansen decided to start the trial process again from the beginning, as opposed to simply rewriting the PMA filing. In November, IDSI obtained its tenth clinical site with the current possibility of two more additions, in order to obtain the proper subgroups.
Hansen will still be actively consulting for the company.
Jay Bendis, co-chairman of IDSI's board, said, “Tim brought a women's health focus to our business, launched a comprehensive global commercialization program, led our advanced technology efforts and guided us through strategic matters. He has agreed to a limited term consulting agreement to aid in our transition process.”
Hansen held a number of leadership positions prior to IDSI, including as the president of Picker International, a manufacturer of diagnostic imaging systems, until April 2001, according to the company.
In the interim, Allan Schwartz, the current executive vice president, and Deborah O’Brien, the current senior vice president, will collaboratively work with other IDSI executives in a committee format to manage the daily workings of the company and actively begin the search for a new CEO.
Hansen was hired in 2004, a year after IDSI’s premarket approval (PMA) filing failed to gain FDA approval for its non-invasive CT laser mammography technology. As CEO, Hansen decided to start the trial process again from the beginning, as opposed to simply rewriting the PMA filing. In November, IDSI obtained its tenth clinical site with the current possibility of two more additions, in order to obtain the proper subgroups.
Hansen will still be actively consulting for the company.
Jay Bendis, co-chairman of IDSI's board, said, “Tim brought a women's health focus to our business, launched a comprehensive global commercialization program, led our advanced technology efforts and guided us through strategic matters. He has agreed to a limited term consulting agreement to aid in our transition process.”